New Drug Controller of India (DCGI) takes over

New Delhi: Dr Eshwar Reddy is the new Drug Controller of India (DCGI). He takes over the charge from Dr G.N. Singh.

Dr Reddy bucks the trend in the sense that he is not a political appointee. He is from within the department and is seized of a well thought out Pharma vision 2030.  Perhaps After a long time, he is a professional appointee as in the past most DCGI were political nominations from outside department. For long term Pharma vision, he is considered the most eligible one for this post.

Dr Reddy has leadership qualities and it is hugely hoped that he would come out with flying colours during his three month probation. Medical device sector has been his pet subject.

Rajiv Nath, Forum Coordinator, Association of Indian Medical device industry (AiMeD), has expressed utmost pleasure on his appointment and not being a political appointee. Dr Reddy was joint drug controller of India.

  • Related Posts

    Aurobindo Pharma Board approves ₹800 cr share buyback plan

    Generic drugmaker is proposing to buyback more than 54.23 lakh equity shares at ₹1,475 each, fixes April 17, 2026 as the record date Aurobindo Pharma’s Board has approved the generic…

    Three held for cheating SCB Hospital patients on promise of arranging blood

    Cuttack: Police have busted a broker racket operating around the SCB Medical College and Hospital in Cuttack and arrested three accused who allegedly cheated patients and their attendants on the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Aurobindo Pharma Board approves ₹800 cr share buyback plan

    Aurobindo Pharma Board approves ₹800 cr share buyback plan

    Three held for cheating SCB Hospital patients on promise of arranging blood

    Three held for cheating SCB Hospital patients on promise of arranging blood

    NATHEALTH resolves to evolve to fit The Bill of Viksit Bharat

    NATHEALTH   resolves to evolve to fit The Bill of Viksit Bharat

    Cancer drug makers seek 50% price hike as platinum surge hits production viability

    Cancer drug makers seek 50% price hike as platinum surge hits production viability

    CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

    CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

    Delhi Police busts racket diverting govt-supplied medicines for private sale; 3 held

    Delhi Police busts racket diverting govt-supplied medicines for private sale; 3 held